Shalini Padhy, Pia Johansson. Financing High-Cost Gene Therapy Under Clinical Uncertainty: Assessing Budget Impact of Reimbursement Models for Hemgenix® in Hemophilia B in Sweden. // Applied Health Economics and Health Policy. – 2026. – DOI: 10.1007/s40258-026-01077-9. – URL: https://doi.org/10.1007/s40258-026-01077-9
Shalini Padhy & Pia Johansson (2026). Financing High-Cost Gene Therapy Under Clinical Uncertainty: Assessing Budget Impact of Reimbursement Models for Hemgenix® in Hemophilia B in Sweden. Applied Health Economics and Health Policy. https://doi.org/10.1007/s40258-026-01077-9
Shalini Padhy and Pia Johansson. “Financing High-Cost Gene Therapy Under Clinical Uncertainty: Assessing Budget Impact of Reimbursement Models for Hemgenix® in Hemophilia B in Sweden.” Applied Health Economics and Health Policy, 2026. doi:10.1007/s40258-026-01077-9.
@article{Padhy2026,
title = {Financing High-Cost Gene Therapy Under Clinical Uncertainty: Assessing Budget Impact of Reimbursement Models for Hemgenix® in Hemophilia B in Sweden},
author = {Padhy, Shalini and Johansson, Pia},
journal = {Applied Health Economics and Health Policy},
year = {2026},
doi = {10.1007/s40258-026-01077-9},
url = {https://doi.org/10.1007/s40258-026-01077-9}
}